Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 10125150 Crystalline forms of a PI3K inhibitor

Patent 10125150 was granted and assigned to Incyte on November, 2018 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Applicant

0

Current Assignee

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Yun-Long Li0

Brian W. Metcalf0

Hui-Yin Li0

Date of Patent

November 13, 2018

0

Patent Application Number

159804000

Date Filed

May 15, 2018

0

Patent Citations Received

US Patent 12024522 Salts and processes of preparing a PI3K inhibitor

0

US Patent 10646492 Heterocyclylamines as PI3K inhibitors

0

US Patent 10829502 Pyrimidinones as PI3K inhibitors

US Patent 11401280 Pyrimidinones as PI3K inhibitors

US Patent 11819505 Heterocyclylamines as PI3K inhibitors

0

US Patent 11433071 Heterocyclylamines as PI3K inhibitors

US Patent 11999751 Bicyclic heteroarylaminoalkyl phenyl derivatives as PI3K inhibitors

0

US Patent 10336759 Salts and processes of preparing a PI3K inhibitor

...

Patent Primary Examiner

0

Patent abstract

The present invention is related to crystalline forms of (S)-7-(1-(9H-purin-6-ylamino)ethyl)-6-(3-fluorophenyl)-3-methyl-5H-thiazolo[3,2-a]pyrimidin-5-one which is a PI3K inhibitor useful in the treatment of cancer and other diseases.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10125150 Crystalline forms of a PI3K inhibitor

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool